Zobrazeno 1 - 10
of 774
pro vyhledávání: '"Nakao IWATA"'
Autor:
Takuma Ashizawa, Takeo Saito, Tomo Okochi, Kohei Ninomiya, Kenta Ito, Rei Aoki, Masashi Ikeda, Nakao Iwata
Publikováno v:
Translational Psychiatry, Vol 14, Iss 1, Pp 1-6 (2024)
Abstract Recent genome-wide association studies (GWASs) have identified fatty acid desaturase (FADS) genes, which code key enzymes involved in polyunsaturated fatty acid (PUFA) desaturation as susceptibility genes for bipolar disorder (BD). Several q
Externí odkaz:
https://doaj.org/article/56eb7c612794453f88a8142b4c522676
Publikováno v:
Translational Psychiatry, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Insomnia is highly comorbid in patients with psychiatric disorders, including depression, bipolar disorder, and substance use disorders, and should be treated as an independent condition. Dual orexin receptor antagonists (DORAs) have been in
Externí odkaz:
https://doaj.org/article/ab8a3f457ec3400ea66278dd7ff36b2a
Autor:
Jun Ishigooka, Kazuyuki Nakagome, Tetsuro Ohmori, Nakao Iwata, Ken Inada, Jun-ichi Iga, Taro Kishi, Kiyoshi Fujita, Yuka Kikuchi, Toshiaki Shichijo, Hideaki Tabuse, Shotatsu Koretsune, Hiroshi Terada, Haruko Terada, Toshifumi Kishimoto, Yuichiro Tsutsumi, Kazutaka Ohi
Publikováno v:
BMC Psychiatry, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background We report the final results of treatment with aripiprazole, blonanserin, and paliperidone from the Japan Useful Medication Program for Schizophrenia (JUMPs), a 104-week naturalistic study. Methods JUMPs was an open-label, three-ar
Externí odkaz:
https://doaj.org/article/3f53087d162b46e39d3f2481014020a5
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 2, Pp 424-436 (2024)
Abstract Aim This study aimed to verify the real‐world efficacy and safety of quetiapine fumarate extended‐release tablets (Bipresso® 50 mg and 150 mg; marketing authorization holder is KYOWA Pharmaceutical Industry Co., Ltd., Osaka, Japan) in p
Externí odkaz:
https://doaj.org/article/186f3b98720540a8b084a5363c8ceee9
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 1, Pp 165-175 (2024)
Abstract Aim This systematic review and frequentist network meta‐analysis used random‐effects models is conducted to determine whether there are differences in the efficacy, acceptability, tolerability, and safety profiles of brexpiprazole (BRE)
Externí odkaz:
https://doaj.org/article/295d7df1367c46ba8da15b0a8269c872
Autor:
Taro Kishi, Kenji Sakuma, Masakazu Hatano, Takenori Okumura, Masaki Kato, Hajime Baba, Nakao Iwata
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 1, Pp 267-271 (2024)
Abstract Aim To update the major depressive disorder (MDD) treatment guidelines of the Japanese Society of Mood Disorders, we conducted a systematic review and pairwise meta‐analysis of double‐blind, randomized, placebo‐controlled trials of ava
Externí odkaz:
https://doaj.org/article/473c75bb15464286a3387b7057e954ba
Autor:
Taro Kishi, Kenji Sakuma, Masakazu Hatano, Yuki Matsuda, Satoru Esumi, Nobumi Miyake, Itaru Miura, Hikaru Hori, Masaki Kato, Nakao Iwata
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 1, Pp 216-220 (2024)
Abstract Introduction The question remains to be elucidated: “Is treatment with antidepressants at doses approved in Japan effective for Japanese patients with MDD?” It is crucial to confirm this in order to provide appropriate treatments for Jap
Externí odkaz:
https://doaj.org/article/7bd9cab4e4ec4052919a8dd7b78746e1
Autor:
Tzuyao Lo, Itaru Kushima, Hiroki Kimura, Branko Aleksic, Takashi Okada, Hidekazu Kato, Toshiya Inada, Yoshihiro Nawa, Youta Torii, Maeri Yamamoto, Ryo Kimura, Yasuko Funabiki, Hirotaka Kosaka, Shusuke Numata, Kiyoto Kasai, Tsukasa Sasaki, Shigeru Yokoyama, Toshio Munesue, Ryota Hashimoto, Yuka Yasuda, Michiko Fujimoto, Masahide Usami, Masanari Itokawa, Makoto Arai, Kazutaka Ohi, Toshiyuki Someya, Yuichiro Watanabe, Jun Egawa, Tsutomu Takahashi, Michio Suzuki, Hidenori Yamasue, Nakao Iwata, Masashi Ikeda, Norio Ozaki
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 1, Pp 42-50 (2024)
Abstract Aim The present study aimed to examine the association between copy number variations (CNVs) in parkin (PRKN) and schizophrenia (SCZ) and autism spectrum disorder (ASD) in a large case–control sample. Method Array comparative genomic hybri
Externí odkaz:
https://doaj.org/article/7c5247e49f9446b48f67640ae93b6ce0
Autor:
Kota Funahashi, Marina Hirose, Suguru Kondo, Yoshimi Sano, Shiho Fujita, Nakao Iwata, Tsuyoshi Kitajima
Publikováno v:
Fujita Medical Journal, Vol 9, Iss 3, Pp 218-224 (2023)
Objectives: We evaluated the continuity and effectiveness of oral appliances (OAs) for treating obstructive sleep apnea (OSA) in a psychiatric sleep clinic, specifically focusing on mild cases and those with psychiatric comorbidity. Methods: We re
Externí odkaz:
https://doaj.org/article/1d5f7ec826c548ebba177dacdc7cfdb5
Autor:
Rina Yokoi, Masakazu Hatano, Hiroyuki Kamei, Aoi Morita, Manako Hanya, Nakao Iwata, Shigeki Yamada
Publikováno v:
Fujita Medical Journal, Vol 9, Iss 3, Pp 231-235 (2023)
Objectives: To investigate the subjective assessments of an antipsychotic treatment with brexpiprazole. Methods: This was a 14-week prospective observational study. Nineteen patients participated in the study between February 2019 and January 2020
Externí odkaz:
https://doaj.org/article/9a0de0d007e440e9b565ff158b453a9c